Welcome international healthcare professionals

Welcome, this website is intended for healthcare professionals with an interest in the ECC Webcasts. By clicking the button below you are declaring and confirming that you are a healthcare professional.

You are here

Introduction

M. Aapro (Switzerland)

SlotAE-1 Introduction

Welcome and presentation of the agenda by the co-chairman Dr. Matti Aapro

Transcription

A very good evening, I am Matti Aapro, Medical Oncologist based in Genolier, in Switzerland, and I am here with Mary O’Brien, Clinical Oncologist based in the UK, and it is our privilege to be co-chairing this session on “Metastatic Breast Cancer, Non Small Cell Lung Cancer: Let’s talk about disease control”.  

Full transcription

Full transcription

A very good evening, I am Matti Aapro, Medical Oncologist based in Genolier, in Switzerland, and I am here with Mary O’Brien, Clinical Oncologist based in the UK, and it is our privilege to be co-chairing this session on “Metastatic Breast Cancer, Non Small Cell Lung Cancer: Let’s talk about disease control”. 

MBC & NSCLC:  Let’s Talk About Disease Control

After a few slides of introduction I will be asking Mary O’Brien to lead you into the question ‘What is disease control?’, before we move to two experts, one in breast cancer, Marina Cazzaniga, and one in lung cancer, Francesco Grossi, who will be sharing with you some thoughts about a new approach to disease control, maintaining this with a metronomic treatment, and then we will have some conclusions. 

As some of you might be wondering ‘What is metronomic treatment actually and what does it really do?’ we have the great privilege to have with us Professor Gérard Milano, who is going to give us the science behind the clinical observations.